Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

23 trials with published results (23%)

Research Maturity

78 completed trials (76% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

6.9%

7 terminated out of 102 trials

Success Rate

91.8%

+5.3% vs benchmark

Late-Stage Pipeline

30%

31 trials in Phase 3/4

Results Transparency

29%

23 of 78 completed with results

Key Signals

23 with results92% success

Data Visualizations

Phase Distribution

75Total
Not Applicable (21)
P 1 (6)
P 2 (17)
P 3 (19)
P 4 (12)

Trial Status

Completed78
Unknown8
Terminated7
Not Yet Recruiting4
Recruiting2
Withdrawn2

Trial Success Rate

91.8%

Benchmark: 86.5%

Based on 78 completed trials

Clinical Trials (102)

Showing 20 of 20 trials
NCT07383493Not ApplicableNot Yet Recruiting

RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis

NCT07348302Phase 3RecruitingPrimary

Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

NCT06291402RecruitingPrimary

Nasal Packing Duration and Development of Pharyngitis After Septorhinoplasty Surgery

NCT06448585Phase 4CompletedPrimary

Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy.

NCT07140250Not ApplicableCompleted

Using ChatGPT to Help Guide Treatment for Sinus and Nasal Problems

NCT06812676Not ApplicableCompleted

Virtual Reality Induced Analgesia for Nasal Procedures

NCT04012216CompletedPrimary

Sleep Respiratory Disorders in Patients With Moderate to Severe Persistent Rhinitis

NCT03952845Not ApplicableNot Yet Recruiting

Intranasal Capsaicinoid Spray

NCT06498843Not ApplicableNot Yet RecruitingPrimary

Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections/Conditions

NCT06350448Not ApplicableNot Yet RecruitingPrimary

Washed Microbiota Transplantation for Rhinitis

NCT05999955Not ApplicableCompleted

Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis

NCT05960318Completed

Post Market Clinical Follow-Up Study - Medical Device KalobaNaso

NCT00541255Completed

A Long-Term Examination of Asthma From Childhood Through Adolescence

NCT00723736CompletedPrimary

Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)

NCT00704769CompletedPrimary

Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299)

NCT00724698CompletedPrimary

Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria

NCT02654223Phase 2CompletedPrimary

Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy

NCT02784262Phase 2Completed

Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Chronic Rhinosinusitis With Nasal Polyposis

NCT02360072CompletedPrimary

Airway Inflammation and Bronchial Hyperresponsiveness in Rhinitic Children With or Without Asthma

NCT04132570Phase 4CompletedPrimary

A Study of Intranasal Budesonide Aqueous Spray for Treatment of Rhinitis During Periods of High Airborne Pollution

Scroll to load more

Research Network

Activity Timeline